Results 81 to 90 of about 9,874 (219)

Evolution of Bordetella pertussis in the acellular vaccine era in Norway, 1996 to 2019. [PDF]

Eur J Clin Microbiol Infect Dis, 2022
Brandal LT, Vestrheim DF, Bruvik T, Roness RB, Bjørnstad ML, Greve-Isdahl M, Steens A, Brynildsrud OB.   +7 more
europepmc   +1 more source

Cellular and Acellular Pertussis Vaccines in Adults [PDF]

Clinical Infectious Diseases, 1999
Immunization against pertussis after childhood previously was considered unnecessary, because severe illness and complications rarely developed in older persons. The rising incidence of pertussis among older adolescents and adults and the transmission of infection from adults to infants suggest that booster immunization may be necessary to more ...
openaire   +2 more sources

Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial

, 2021
<p>Background: Transplacentally transferred antibodies induced by maternal pertussis vaccination interfere with infant immune responses to pertussis primary vaccination.
Rumlarova, Sarka, Halperin, Scott A, de la Cueva, Ignacio Salamanca, Ceregido, Maria Angeles, Kuriyakose, Sherine O, Kosina, Pavel, Miranda-Valdivieso, Mariano, Nolan, Terry, Kostanyan, Lusine, Halperin, Scott A., Janota, Jan, Palomino, Esperanza Escribano, Perrett, Kirsten P., García-Sicilia, José, Perrett, Kirsten P, Vanderkooi, Otto G, Virta, Miia, Bozensky, Jan, Kuriyakose, Sherine O., Arribas, Jose M.Merino, Vanderkooi, Otto G., Baca, Manuel, Novas, Begoña Arias, Zuccotti, Gian Vincenzo, Mesaros, Narcisa, Arribas, Jose M Merino, Amador, Jose Tomas Ramos, Meyer, Nadia, Cheuvart, Brigitte, Martinón-Torres, Federico, Stranak, Zbynek, Ortega, María José Cilleruelo, Tapiéro, Bruce, Marchisio, Paola Giovanna   +33 more
core   +1 more source

Immunogenicity and protective efficacy of a newly developed tri-component diphtheria, tetanus, and acellular pertussis vaccine in a murine model

Journal of Microbiology, Immunology and Infection, 2018
Background/Purpose: Although assessing the immunogenicity and protective efficacy of acellular pertussis (aP) vaccines via murine model studies faces limitations, preliminary assessments have been achieved by evaluating respiratory challenge and humoral ...
Dong Ho Huh, Seung Beom Han, Hye Jo Shin, Dong Ho Ahn, Gi Sub Choi, Kyu Ri Kang, Bo Ram Kim, Jin Han Kang   +7 more
doaj   +1 more source

A system-view of Bordetella pertussis booster vaccine responses in adults primed with whole-cell versus acellular vaccine in infancy. [PDF]

JCI Insight, 2021
da Silva Antunes R, Soldevila F, Pomaznoy M, Babor M, Bennett J, Tian Y, Khalil N, Qian Y, Mandava A, Scheuermann RH, Cortese M, Pulendran B, Petro CD, Gilkes AP, Purcell LA, Sette A, Peters B.   +16 more
europepmc   +1 more source

Booster vaccination after neonatal priming with acellular pertussis vaccine

, 2010
After a birth dose of acellular pertussis (aP) and diphtheria (DT)aP-hepatitis B virus (HBV)-inactivated polio vaccine (IPV)/Haemophilus influenza type b (Hib) at 2, 4, and 6 months, a booster dose of DTaP-HBV-IPV/Hib at 12 to 23 months induced strong ...
Knuf, Markus, Meyer, Claudius U., Zepp, Fred, Collard, Alix, Kieninger, Dorothee, Schmitt, Heinz-Josef, Siegrist, Claire-Anne, Jacquet, Jeanne-Marie   +7 more
core   +1 more source

Acellular pertussis vaccine efficacy: An updated systematic review and meta-analysis

, 2016
Background: Recent studies indicate an increased incidence of pertussis disease in recent years. The aim of this study was to evaluate the efficacy of the acellular vaccine for children (as a replacement of current whole cell vaccine in the Expanded ...
Esmaeeli, Shooka, Shokraneh, Farhad, Shakerian, S., Karimi, A., Esmaeeli, S., Mahmoudi, Susan, Shakerian, Sareh, Mansour-Ghanaei, R., Shokraneh, F., Moradi-Lakeh, Maziar, Karimi, Abdollah, Mahmoudi, S., Yaghoubi, Mohsen, Moradi-Lakeh, M., Yaghoubi, M., Mansour-Ghanaei, Roxana   +15 more
core  

Advance system testing: Vaccine benefit studies using multi-country electronic health data - The example of pertussis vaccination

, 2020
The Accelerated Development of VAccine benefit-risk Collaboration in Europe (ADVANCE), a public-private consortium, implemented and tested a distributed network system for the generation of evidence on the benefits-risks of marketed vaccines in Europe ...
de, Lusignan S, Martín-Merino, E, Correa, A, Tramontan, L, de, Ridder M, McGee, C, Duarte-Salles, T, Huerta-Alvarez, C, Braeye, T, Tin, Tin Htar M   +9 more
core   +1 more source

Protective Activity and Safety of Acellular Pertussis Vaccine from Vaccine and Freshly Isolated Strain Bordetella pertussis

, 2017
Goal. Study of the protective activity and safety of acellular pertussis vaccine (APV) using freshly isolated strain of B. pertussis. Materials and methods. Mice-hybrids F1 (CBAxC57Bl6). The B. pertussis strains: vaccine strains No. 305, No. 203, freshly
E. M. Zaitsev, I. G. Bazhanova, M. V. Britsina   +2 more
core   +1 more source

Vaccine [PDF]

Background:The Institute of Medicine, in a 2013 report, recommended that the Vaccine Safety Datalink (VSD) expand collaborations to include more diversity in the study population. Kaiser Permanente Colorado (KPCO), an established VSD site, partnered with

core   +2 more sources